Document is current
Any future updates will be listed below
-
Authors
Mendonça, Rodrigo Holanda https://orcid.org/0000-0001-7520-3353
Ortega, Adriana Banzzatto
Matsui Jr, Ciro
van der Linden, Vanessa
Kerstenetzky, Marcelo
Grossklauss, Luis Fernando
Silveira-Lucas, Elizabeth L.
Polido, Graziela Jorge
Zanoteli, Edmar
- License Information
-
More Information
Article History
Received: 30 January 2023
Revised: 30 April 2024
Accepted: 9 May 2024
First Online: 5 June 2024
Competing interests
: RHM received fee from Novartis for speaking at symposia and participating in clinical trials. ABO received fee from Novartis for speaking at symposiums. EZ received fee from Novartis for speaking at symposia and participating in clinical trials. Other authors declare no conflicts of interest in relation to this publication.
: The study was approved by the Ethics and Research Committee of the Faculdade de Medicine da Universidade de São Paulo (FMUSP), under reference number 87773118.7.0000.0068. An informed consent was obtained from all subjects for retrospective data collection.
